Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Resolute Integrity Drug-Eluting Stent (DES) (formerly Resolute)
print preview
bookmark
share with colleague
General Information
Company
Medtronic Inc.
Description
Zotarolimus-eluting coronary stent utilizing the BioLinx polymer
Molecular Target
FK506 binding protein (macrophilin-12)
Mechanism of Action
Mammalian target of rapamycin (mTOR) kinase inhibitor
Latest Stage of Development
Marketed
Indication
Coronary artery disease (CAD)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy